Articles
| Open Access |
https://doi.org/10.37547/
EARLY DRUG THERAPY FOR FACIAL INFANTILE HEMANGIOMAS: A COMPARATIVE ANALYSIS
Mukhammadali Karimov , PhD, Associate Professor, Department of medical faculty Impuls Medical Institute, Namangan, Uzbekistan 160100 Xurshida Nurmatova , PhD, Associate Professor, Department of morphology and physiology Namangan state university medical faculty, Namangan, Uzbekistan 160100 teacher, Department of Theraphy, Kasansay Medical technicum by names Abu Ali ibn Sino, Kasansay, Uzbekistan 160100Abstract
Infantile hemangioma (IH) is a common benign vascular tumor in children. Although propranolol has proven to be effective in the conservative treatment of infantile hemangiomas, it has several disadvantages, such as the fact that it is given in the form of tablets, it is given in large doses, and it is difficult to dose. In clinical practice, propranolol dosages should be increased from 1 mg/kg per day to 2-4 mg/kg per day. Our research investigation seeks to evaluate the effectiveness of medical therapies in infants and young children who are breastfed under one year of age.
Keywords
hemangioma, propranolol, infantile, facial, children, breastfed, dopplerography, beta-blocker.
References
Mazhar A, Ghouse AN, Mallick YA, Samad L. Efficacy of 0.5% timolol maleate gel in the management of infantile hemangiomas. Pakistan Journal of Medical Sciences. 2023;40(2(ICON)). doi:10.12669/pjms.40.2(icon).8983
Huang CY, Perman MJ, Yan AC. Regimen for accelerated propranolol initial dosing (RAPID). Pediatric Dermatology. Published online April 17, 2024. doi:10.1111/pde.15623
Bandera AIR, Sebaratnam DF, Wargon O, Wong LCF. Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment. Journal of the American Academy of Dermatology. 2021;85(6):1379-1392. doi:10.1016/j.jaad.2021.08.019
O’Connor C, Murphy M. The burden of treatment of propranolol for infantile hemangiomas: A mixed methods study. Pediatric Dermatology. Published online May 22, 2024. doi:10.1111/pde.15652
Chen Q, Chang SJ, Gao W, Chang L, Qiu Y, Lin X. Practical surgical technique using the SMISS approach for lip reduction in involuted lip infantile hemangiomas. BMC Pediatrics. 2024;24(1). doi:10.1186/s12887-024-04838-4
Chakhunashvili K, Kvirkvelia E, Todua N, Chakhunashvili DG. Rare complication – skin atrophy – after systemic conservative therapy of infantile hemangioma. BMC Pediatrics. 2024;24(1). doi:10.1186/s12887-024-04638-w
Núñez-Martínez PM, García-Delgado C, Morán-Barroso VF, Jasso-Gutiérrez L. Congenital macroglossia: clinical features and therapeutic strategies in pediatric patients. Boletín Médico Del Hospital Infantil De México (English Edition). 2016;73(3):212-216. doi:10.1016/j.bmhime.2017.08.003
Helal I, Hasnaoui A, Daïb A, Jouini R, Khanchel F, Debbiche AC. Management of a small bowel hemangioma causing intussusception in an infant: A rare case report and literature review. International Journal of Surgery Case Reports. 2024;122:110108. doi:10.1016/j.ijscr.2024.110108
Saraniti C, Burrascano D, Comincini I, Martorana A, Verro B. Transoral surgery with Thunderbeat© for hemangioma of the tongue base: A novel procedure. Case report. International Journal of Surgery Case Reports. Published online February 1, 2024:109385. doi:10.1016/j.ijscr.2024.109385
Zahran MF, Yuri P. A rare pediatric scrotal hemangioma: A case report and comprehensive analysis of n Bloc Excision as definitive treatment. International Journal of Surgery Case Reports. 2024;116:109347. doi:10.1016/j.ijscr.2024.109347
Xu Z, Zhou J, Chen Y, et al. MEK inhibitors for the treatment of extracranial arteriovenous malformations. Chinese Journal of Plastic and Reconstructive Surgery. 2023;5(3):141-144. doi:10.1016/j.cjprs.2023.09.001
Calderón-Castrat X, Velásquez F, Castro R, Ballona R. Atenolol oral en el manejo del hemangioma infantil: serie de casos de 46 pacientes. Actas Dermo-Sifiliográficas. 2020;111(1):59-62. doi:10.1016/j.ad.2019.03.015
Lauzier DC, Chiang SN, Moran CJ. Etiologies of Brain Arteriovenous Malformation Recurrence: A focus on pediatric disease. Pediatric Neurology. 2023;148:94-100. doi:10.1016/j.pediatrneurol.2023.08.022
Laranjo S, Costa G, Paramés F, et al. The role of propranolol in the treatment of infantile hemangioma. Revista Portuguesa De Cardiologia. 2014;33(5):289-295. doi:10.1016/j.repc.2013.10.018
Colmenero-Sendra M, Del Boz-González J, Torres EB, et al. Parental assessment of infantile hemangioma cosmetic clinical outcomes: results of the Spanish Hemangioma Nationwide Prospective Cohort. Actas Dermo-Sifiliográficas. Published online July 1, 2024. doi:10.1016/j.ad.2024.06.010
Ke C, Chen C, Yang M, Chen H, Li L, Ke Y. Revealing the mechanism of 755-nm long-pulsed alexandrite laser in inhibiting infantile hemangioma endothelial cells through transcriptome sequencing. Lasers in Medical Science. 2024;39(1). doi:10.1007/s10103-023-03967-z
Xiang S, Gong X, Qiu T, et al. Insights into the mechanisms of angiogenesis in infantile hemangioma. Biomedicine & Pharmacotherapy. 2024;178:117181. doi:10.1016/j.biopha.2024.117181
Toledo-Bahena ME, Camargo-Sánchez KA, La Cruz HVD, et al. Guía mexicana para el diagnóstico y el tratamiento del hemangioma infantil. Boletín Médico Del Hospital Infantil De México. 2024;81(92). doi:10.24875/bmhim.24000069
Kwak JH, Yang A, Jung HL, et al. Cardiac Evaluation before and after Oral Propranolol Treatment for Infantile Hemangiomas. Journal of Clinical Medicine. 2024;13(11):3332. doi:10.3390/jcm13113332
Bardo DME, Gill AE, Iyer RS, et al. ACR Appropriateness Criteria® Soft tissue vascular anomalies: vascular malformations and infantile vascular tumors (Non-CNS)-Child. Journal of the American College of Radiology. 2024;21(6):S310-S325. doi:10.1016/j.jacr.2024.02.030
Article Statistics
Downloads
Copyright License
This work is licensed under a Creative Commons Attribution 4.0 International License.